Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Methylprednisolone vs Ibuprofen for IANB Efficacy in Irreversible Pulpitis
NCT04157036Phase 3Terminated
- Sponsor
- Walter Reed National Military Medical Center
- Start
- Feb 2020
- Primary completion
- Sep 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of methylprednisolone in irreversible pulpitis (2 arms), sponsored by Walter Reed National Military Medical Center. Primary endpoint: Analgesic Effect on Nerve Block at 48 hours. Started Feb 2020; status: terminated.
02
Drugs
methylprednisolone
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT04157036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04157036.